• Co-Diagnostics will hold its annual shareholder meeting in Salt Lake City on Sept. 3, 2026.
• Shareholders will vote on electing five directors for one-year terms.
• Ballots include a 2,000,000-share increase to the 2025 Equity Incentive Plan share reserve.
• Items also include a non-binding vote on executive pay plus ratification of Tanner as auditor for fiscal 2026.
• Shareholders will vote on lowering the meeting quorum threshold to one-third of voting shares plus authorizing adjournment to seek additional support.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Co-Diagnostics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-032734), on July 10, 2026, and is solely responsible for the information contained therein.